NCT01573949View on ClinicalTrials.gov

A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
DiabetesHeart Failure
Interventions
DRUG

Metformin

Metformin will be started at 500 mg PO BID and pending lab values may be titrated to 1000 mg PO BID at 1 month for a duration of 3 months.

Trial Locations (1)

90095

Ahmanson-UCLA Cardiomyopathy Center, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT01573949 - A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes) | Biotech Hunter | Biotech Hunter